期刊文献+

骨科围手术期限制性输血和开放性输血的临床疗效对比 被引量:12

Clinical Observation of Orthopedic Perioperative Limiting Blood Transfusion or Opened Blood Transfusion
在线阅读 下载PDF
导出
摘要 目的:对比分析骨科围手术期中限制性输血和开放性输血的临床疗效及不良反应。方法选择2013年1月至2014年6月我院骨科围手术期进行输血的患者作为研究对象,按照随机数字表法分为限制性输血组和开放性输血组各31例,开放性输血组:当Hb〈100g/L时输注红细胞,使Hb维持在100g/L以上;限制性输血组:当Hb〈70 g/L时输注红细胞,使Hb维持在70~100g/L。结果两组的住院时间、拆线时间、术中低血压发生率和切口感染率比较差异无统计学意义(P〉0.05),但开放性输血组的人均用血量、人均输血费用和输血不良反应明显高于限制性输血组,差异有统计学意义(P〈0.05)。结论对骨科围手术期患者应当进行限制性输血。 Objective To compare the clinical efficacy and adverse reaction of orthopedic perioperative limiting blood transfusion and opened blood transfusion. Methods The patients who undergoing orthopedic perioperative blood transfusionIn January 2013 to June 2014 in our hospital as the research object, according to the random number table into limiting blood transfu-sion group and opened blood transfusion group, 31 cases each. Opened blood transfusion group:the group started blood transfusion when Hb was lower than 100g/L,so that Hb was maintained at 100g/L or more;limiting blood transfusion group:the group started transfusion only when the Hb level was lower than 70g/L,so that Hb was mainained at 70 ~100g/L. Results There were no difference(P〉0. 05)between the two groups in the amount of the time stay in hospital,take out stitches time,occurrence of hypo-tension during the operation and the wound infection. But the amount of intraoperative blood transfusion,the cost of blood transfu-sion,and the adverse in group limiting blood transfusion were obviously lower than the group opened blood transfusion(P〈0. 05). Conclusion Patients with orthopedic perioperative blood transfusion should be restricted.
出处 《四川医学》 CAS 2015年第9期1290-1292,共3页 Sichuan Medical Journal
关键词 限制性输血 开放性输血 围手术期 骨科 restrictive blood transfusion opened blood transfusion perioperative orthopedic
  • 相关文献

参考文献11

二级参考文献61

  • 1丁昊烜,丁昊炜.围手术期1214次输血情况的调查和分析[J].临床输血与检验,2001,3(2):45-46. 被引量:3
  • 2卢瑾,田兆嵩.危重病人的输血[J].中国输血杂志,2007,20(2):175-178. 被引量:15
  • 3OFFNER P J. Age of blood: does it make a difference?[J]. Crit Care, 2004, 8 (Suppl 2): S24-S26.
  • 4HO J, SIBBALD W J, Chin-Yee I H. Effects of storage on efficacy of red cell transfusion: when is it not safe? [J]. Crit Care Med, 2003, 31(Suppl 12): S687-S697.
  • 5ZILBERBERG M D, CARTER C, LEFEBVRE P, et al. Red blood cell transfusions and the risk of acute respiratory distress syndrome among the critically ill~ a cohort study[J].Crit Care, 2007, 11(3): R63.
  • 6CORWIN H L, CARSON J L. Blood transfusion-when is more really less? [J].N Engl J Med, 2007, 356(16): 1667- 1669.
  • 7HYUNG W J, NOH S H, SHIN D W,et al. Adverse effects Of perioperative transfusion on patients with stage lI and IV gastric cancer[J]. Ann Surg Oncol, 2002, 9(1) : 5-12.
  • 8SHEN J G, CHEONG J H, HYUNAG W J, et al. Pretreatment anemia is associated with poorer survival in patients with stage I and Ⅱ gastric cancer [J]. J Surg Oncol, 2005, 91(2): 126-130.
  • 9MURPHY G J, REEVES B C, ROGERS C A, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery [J]. Circulation, 2007, 116(22): 2544-2552.
  • 10KOCH C G, LI L, SESSLER D I, et al. Duration of red-cell storage and complications after cardiac surgery[J]. N Engl J Med, 2008, 358(12): 1229-1239.

共引文献111

同被引文献71

引证文献12

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部